MEDP — Medpace Holdings, Inc.
Healthcare • Medical - Diagnostics & Research
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from...…
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $548.12
- Day High
- $552.05
- Day Low
- $541.02
- 52w High
- $626.26
- 52w Low
- $250.05
- Volume
- 79,150
- Avg Volume
- Beta
- 1.431
* TTM/most recent where available
Company
- Ticker
- MEDP
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
- CEO
- August James Troendle
- Employees
- 5900
- Website
- www.medpace.com
Key Metrics
- Market Cap
- 15.5B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).